pembrolizumab
merck
['pembro']
today at 6 pm ct: dr. ryan lynch of fred hutch to present updated clinical results of untreated chl patients treated with concurrent pembrolizumab + avd with correlation of dynamic ctdna monitoring as well as data on total metabolic tumor volume. #ash22 
Making life beyond cancer a reality.